PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$5.25
+0.17 (+3.35%)
Open$5.26
Previous Close$5.08
Day High$5.31
Day Low$5.04
52W High$18.31
52W Low$5.02
Volume—
Avg Volume2.47M
Market Cap421.50M
P/E Ratio—
EPS$-1.27
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+866.5% upside
Current
$5.25
$5.25
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 192.80M | 173.93M | 162.51M |
| Net Income | -243,600,920 | 52.15M | 46.06M |
| Profit Margin | -126.4% | 30.0% | 28.4% |
| EBITDA | -175,446,935 | 99.13M | 88.44M |
| Free Cash Flow | — | 45.89M | 35.44M |
| Rev Growth | — | -4.6% | -5.1% |
| Debt/Equity | 1.24 | 0.67 | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |